Advertisement

Topics

Baxter International Inc. and Halozyme Therapeutics, Inc. Company Profile

21:45 EDT 23rd June 2018 | BioPortfolio

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.


News Articles [1071 Associated News Articles listed on BioPortfolio]

Halozyme Therapeutics, Inc. (HALO) Expected to Post Earnings of -$0.21 Per Share

Analysts predict that Halozyme Therapeutics, Inc. will post earnings per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Halozyme Th...

Deals this week: Melinta Therapeutics, Cipher Pharmaceuticals, Baxter International

Melinta Therapeutics plans to raise $114.88m by issuing 6,920,714 shares of its common stock, priced at $16.6 a share. The US-based...Read More... The post Deals this week: Melinta Therapeutics, Ciph...

Halozyme, Edico CEOs Among San Diego’s Entrepreneurs of the Year

Helen Torley, who was highlighted in 2016 as the only female CEO of a public life sciences company in San Diego, was recognized last week for her operational excellence at Halozyme Therapeutics (NASDA...

Baxter, ISN partner to address growing prevalence of kidney disease

Baxter International Inc., a global innovator in renal (kidney) care, and the International Society of Nephrology (ISN), announced a partnership to advance chronic kidney disease (CKD) awareness and h...

Halozyme Therapeutics, Inc. 2018 Q1 - Results - Earnings Call Slides

Halozyme Therapeutics, Inc. 2017 Q4 - Results - Earnings Call Slides

Halozyme Therapeutics' (HALO) CEO Helen Torley on Q1 2018 Results - Earnings Call Transcript

Halozyme Therapeutics' (HALO) CEO Helen Torley on Q4 2017 Results - Earnings Call Transcript

Drugs and Medications [596 Associated Drugs and Medications listed on BioPortfolio]

Sterile water [BAXTER HEALTHCARE CORPORATION]

Directions for Use of Flexible Plastic Irrigation Containers

Hylenex recombinant [Baxter Healthcare Corporation]

These highlights do not include all the information needed to use HYLENEX recombinant safely and effectively. See full prescribing information for HYLENEX recombinant. HYLENEX recombinant (hyaluronida...

Aldex [Pernix Therapeutics, LLC]

ALDEX GS™ Tablets

Aldex [Pernix Therapeutics, LLC]

ALDEX GS DMTablets

Pro-den rx [Zila Therapeutics, Inc.]

Pro-Den Rx

PubMed Articles [1005 Associated PubMed Articles listed on BioPortfolio]

Commentary: Roger Baxter.

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Corrigendum.

Heinert, S., Del Rios, M., Arya, A., Amirsoltani, R., Quasim, N., Gehm, L., . . . Vanden Hoek, T. (2018). The CHAMPIONS NETWork: Training Chicago high school students as health advocates to improve he...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Clinical Trials [1118 Associated Clinical Trials listed on BioPortfolio]

Investigation of Performance and Compatibility of the Baxter Dialyzer Xenium XPH 210 During On-line Hemodiafiltration

The proposed study seeks to determine the appropriate balance between the removal of undesirable small molecular substances (urea, creatinine, phosphate) and large molecular substances (ß...

Medtronic's MOSAIC Bioprosthesis Versus Baxter Carpentier-Edwards SAV Porcine Valve

The study compares the clinical performance of the Mosaic valve with that of the Baxter valve (Carpentier-Edwards) which is widely used throughout the UK and is considered to be the "bench...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Early Postoperative Cognitive Dysfunction After Closed Loop Anesthesia vs Inhalational Anesthesia or TIVA

This study is designed to test the hypothesis that closed loop system reduces post operative cognitive dysfunction incidence 15 min after anesthesia more than desflurane, sevorane, total i...

Companies [2540 Associated Companies listed on BioPortfolio]

Baxter International Inc. and Halozyme Therapeutics, Inc.

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cance...

Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery m...

Baxter International Foundation

Baxter and Baxter International Foundation are committed to saving and sustaining lives. Every day, Baxter employees strive to make a meaningful difference in the lives of people ...

Halozyme Therapeutics

Halozyme Therapeutics, Inc. is a therapeutically driven, development stage biopharmaceutical company dedicated to developing and commercializing recombinant human enzymes for the infertility, ophthalm...

Baxter International Inc. and Takeda Pharmaceutical Company Limited

Baxter International Inc. (NYSE: BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune d...

More Information about "Baxter International Inc. and Halozyme Therapeutics, Inc." on BioPortfolio

We have published hundreds of Baxter International Inc. and Halozyme Therapeutics, Inc. news stories on BioPortfolio along with dozens of Baxter International Inc. and Halozyme Therapeutics, Inc. Clinical Trials and PubMed Articles about Baxter International Inc. and Halozyme Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Baxter International Inc. and Halozyme Therapeutics, Inc. Companies in our database. You can also find out about relevant Baxter International Inc. and Halozyme Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record